Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Secondary carcinoid tumors of liver
- Also referred to as metastatic neuroendocrine tumors in the liver.
Summary
Secondary carcinoid tumors of the liver are cancerous growths that originate from neuroendocrine cells and have spread to the liver. These tumors are part of a broader category of neuroendocrine tumors and may disrupt normal liver function depending on their location and size.
Causes
The primary cause is the metastasis of a carcinoid tumor from another part of the body, often from the gastrointestinal tract or lungs. The exact mechanism involves the detachment of cancer cells from the primary tumor and their transportation through the bloodstream to the liver.
Risk Factors
- Having a primary neuroendocrine tumor.
- Genetic predispositions, such as Multiple Endocrine Neoplasia (MEN) syndromes.
- Age (more common in older adults).
- A history of previous cancers or prolonged exposure to certain chemicals or radiation.
Symptoms
Symptoms can vary depending on the hormones produced and the location of the metastasis. Common signs include unexplained weight loss, abdominal pain, jaundice, or changes in liver function. Systemic symptoms may also occur if the tumor disrupts normal organ function.
Diagnosis
Diagnosis typically involves imaging studies like CT, MRI, or PET scans to detect tumors in the liver. Biopsy of affected liver tissue may be performed to confirm the presence of neuroendocrine cells. Blood tests to assess liver function and hormone levels may also be used.
Treatment Options
Treatment depends on the extent of the disease and may include surgery to remove tumors, targeted therapies, or systemic treatments like chemotherapy or somatostatin analogs. Liver-directed therapies such as embolization or radioembolization may be considered in some cases.
Prognosis and Follow-Up
Prognosis varies based on factors like the primary tumor type, extent of liver involvement, and overall health. Regular follow-up with imaging and blood tests is typically recommended to monitor for recurrence or progression.
Complications
Complications can include liver dysfunction, pain, or obstruction of bile ducts. In advanced cases, the tumor may cause systemic symptoms due to hormone release or spread to other organs.
Lifestyle & Prevention
While prevention of metastasis is not always possible, managing the primary tumor and maintaining overall health may help reduce risk. Regular medical check-ups are important for early detection.
When to Seek Professional Help
Seek medical attention if you experience unexplained abdominal pain, jaundice, significant weight loss, or other symptoms that may indicate liver involvement.
Tips for Medical Coders
When coding for secondary carcinoid tumors of the liver (C7B.02), ensure documentation specifies the liver as the metastatic site. Verify that the primary tumor origin is documented, as this may impact coding accuracy. Follow guidelines for distinguishing primary vs. secondary tumors to avoid misclassification.
Medical Policies and Guidelines
Related policies from health plans
C7B.02 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.